Health
New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation – News-Medical.Net
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million…
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
The grant will aid the effort to bring further preclinical validation to the AAV vaccine platform. An AAVCOVID vaccine candidate is set to enter clinical trials in 2021.
The AAVCOVID vaccine program was founded at Mass General Brigham at the outset of the pandemic.
Preliminary tests of the vaccines’…
-
Noosa News12 hours agoUniversity of Queensland researchers survey population of endangered White’s Seahorse
-
Noosa News22 hours agoWill the LNP’s new scheme help me become a first-home buyer?
-
General11 hours agoMontana’s house was gutted by an accidental fire. Then her landlord accused her of starting it
-
Noosa News22 hours agoQueensland’s $100 back-to-school bonus, and how it will work